Tag: facility in Songdo
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Featured Article
Reality check: Aussie factories’ journey to responsible AI implementation
Artificial intelligence has become more than just a buzzword as it promises to revolutionise every other industry in the world, including manufacturing. In Australia, in particular, the hype surrounding AI and automation has reached a fever pitch, with many business leaders leveraging their resources to race towards adoption and implementation.
